IN THIS ISSUE:

• PUBLIC HEALTH ADVISORY
  Reports of Valvular Heart Disease in Patients Receiving Concomitant Fenfluramine and Phentermine
• Future Meetings
• Protease Inhibitors May Increase Blood Glucose in HIV Patients
• New Treatment for Orphan Disease, Essential Thrombocythemia
• Natural Rubber Latex Allergy
• Reminder for Physicians Interpreting Mammograms
• Medication Errors
  • Confusion with Brevibloc Injection Dosage Forms
• FDA Warns Against Dietary Supplement Product, "Chomper"
• From the medWatch Office
  • Summaries of "Dear Health Professional" Letters and Other Safety Notifications FDA Requests Help in Evaluating Therapeutic Switches
  • medWatch Continuing Education Article
  • Safety-Related Drug Labeling Changes Approved by FDA
  • Obtaining a medWatch Reporting Form
• Editorial Board
• Change of Address
• FDA Telephone Numbers

FDA/Website Management Staff